Annual report [Section 13 and 15(d), not S-K Item 405]

Segment Information - Schedule of Profit and Loss from Segments (Details)

v3.25.1
Segment Information - Schedule of Profit and Loss from Segments (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Research and development expenses:    
Personnel $ 39,239 $ 22,375
Clinical trials 22,286 8,302
Development Services 16,417 12,486
Manufacturing of preclinical and clinical supplies 15,523 8,498
License of intellectual property 1,523 2,383
Other research and development costs [1] 2,215 1,380
General and administration expenses 27,938 19,236
Interest income (10,025) (6,985)
Interest expense 748 0
Net loss $ 115,864 $ 67,675
[1] Other research and development costs includes costs associated with information technology, travel, medical and scientific symposiums and conferences.